The D.E.A. is failing at its mission.
Tag: Drugs (Pharmaceuticals)
-
California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts
The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
-
F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment
While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.
-
What to Know About the Recent Eye Drop Recalls
Global Pharma recalled eye drops in February after they were tied to a drug-resistant bacteria strain linked to at least one death. Two more companies have since recalled eye drops.
-
Texas Judge Hears Case to End Federal Approval of Abortion Pill
The judge said he would decide soon whether to issue a preliminary injunction ordering the F.D.A. to withdraw its approval of the drug or wait for the full trial.